Results 81 to 90 of about 264 (130)
Noonan Syndrome in South Africa: Clinical and Molecular Profiles
Noonan Syndrome (NS) is a common autosomal dominant multisystem disorder, caused by mutations in more than 10 genes in the Ras/MAPK signaling pathway. Differential mutation frequencies are observed across populations.
Cedrik Tekendo-Ngongang +7 more
doaj +1 more source
American Journal of Hematology, Volume 101, Issue 8, Page 2038-2043, August 2026.
Sankalp Arora +18 more
wiley +1 more source
Background: PTPN11mutations can be found in 1.5%–12% of AML cases. They have been reported to cluster mainly in the N-terminal Src homology region 2 (N-SH2) and phosphatase (PTP) domains.
F. Crupi +15 more
doaj
Juvenile myelomonocytic leukemia (JMML) is a childhood hematological cancer that often results from mutations in the PTPN11 gene. This study aims to report an original proband with JMML, COVID-19, HLH, and mucormycosis phenotypes.
Kübra Aslan +11 more
doaj +1 more source
Mutations of PTPN11 are rare in adult myeloid malignancies.
The PTPN11 gene encodes the phospho-tyrosyine phosphatase protein SHP-2. Constitutional mutations of this gene are involved in Noonan's syndrome, a developmental disorder in which children have a predisposition to develop a myeloid disorder called juvenile myelomonocytic leukemia.
Leroy, Hugues +5 more
openaire +1 more source
Oncogenic PTPN11 Mutations are Rare in Solid Tumors
Eun Mi, Je +3 more
openaire +2 more sources
PTPN11 mutation: Orthopedic outcomes in metachondromatosis
Camille Rabhi +4 more
openaire +1 more source
Heterozygous Mutation of Noonan Syndrome in PTPN11 Genes
openaire +1 more source

